Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Price:
3.18
USD
-1.55%
Market Closed
Market Cap:
$1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
US |
|
B
|
BP PLC
XMUN:BPE5
|
UK |
|
A
|
ArcelorMittal SA
SWB:ARRD
|
LU |
|
Fresenius Medical Care AG & Co KGaA
NYSE:FMS
|
DE |
|
A
|
Assicurazioni Generali SpA
XMUN:ASG
|
IT |
|
Crane Co
F:T12
|
US |
|
H
|
Hyundai Motor Co
KRX:005387
|
KR |
|
R
|
Rambus Inc
XMUN:RMB
|
US |
|
R
|
Rhoen Klinikum AG
XMUN:RHK
|
DE |
Wall St Price Targets
RXRX Price Targets Summary
Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals Inc
Wall Street analysts forecast RXRX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for RXRX is 6.2 USD with a low forecast of 3.03 USD and a high forecast of 10.5 USD.
Lowest Forecast
Price Target
3.03
USD
5% Downside
Average Forecast
Price Target
6.2
USD
95% Upside
Highest Forecast
Price Target
10.5
USD
230% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RXRX's stock price target?
Price Target
6.2
USD
6.2
USD
According to Wall Street analysts, the average 1-year price target for RXRX is 6.2 USD with a low forecast of 3.03 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for Recursion Pharmaceuticals Inc?
Projected CAGR
28%
28%
Over the last 5 years, the compound annual growth rate for Revenue has been 80%. The projected CAGR for the next 3 years is 28%.
